BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4152079)

  • 1. Noradrenaline nerve terminals in the cerebral cortex: effects on noradrenaline uptake and storage following axonal lesion with 6-hydroxydopamine.
    Lidbrink P; Jonsson G
    J Neurochem; 1974 May; 22(5):617-26. PubMed ID: 4152079
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of the blood-brain barrier for 6-hydroxydopamine.
    Sachs C
    J Neurochem; 1973 Jun; 20(6):1753-60. PubMed ID: 4719317
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in the development of central noradrenaline neurones following neonatal administration of 6-hydroxydopamine.
    Jonsson G; Pycock C; Fuxe K; Sachs C
    J Neurochem; 1974 Mar; 22(3):419-26. PubMed ID: 4829965
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes in central noradrenaline neurons after systemic 6-hydroxydopamine administration.
    Sachs C; Jonsson G
    J Neurochem; 1973 Dec; 21(6):1517-24. PubMed ID: 4771442
    [No Abstract]   [Full Text] [Related]  

  • 5. 6-Hydroxydopamine induced degeneration of noradrenaline neurons in the scorbutic guinea-pig.
    Jonsson G; Lohmander S; Sachs C
    Biochem Pharmacol; 1974 Sep; 23(18):2585-93. PubMed ID: 4153539
    [No Abstract]   [Full Text] [Related]  

  • 6. Degeneration of central and peripheral noradrenaline neurons produced by 6-hydroxy-DOPA.
    Sachs C; Jonsson G
    J Neurochem; 1972 Jun; 19(6):1561-75. PubMed ID: 5035304
    [No Abstract]   [Full Text] [Related]  

  • 7. Degeneration of central noradrenaline neurons after 6-hydroxydopamine in newborn animals.
    Sachs C; Jonsson G
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):203-20. PubMed ID: 4671892
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of the effects of neonatal subcutaneous 6-hydroxydopamine on noradrenergic and dopaminergic innervation of the cerebral cortex.
    Schmidt RH; Bhatnagar RK
    Brain Res; 1979 Apr; 166(2):309-19. PubMed ID: 34469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of the intraventricular injection of 6-hydroxydopamine. I. On the cerebral monoamines of the cat].
    Petitjean F; Laguzzi R; Sordet F; Jouvet M; Pujol JF
    Brain Res; 1972 Dec; 48():281-93. PubMed ID: 4645209
    [No Abstract]   [Full Text] [Related]  

  • 10. 6-Hydroxydopamine: effect on mouse brain monoamines and 14C-noradrenaline uptake.
    Masuoka DT; Alcaraz AF
    Eur J Pharmacol; 1973 Nov; 24(2):234-42. PubMed ID: 4765746
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of tyrosine hydroxylase inhibition on the action of 6-hydroxydopamine.
    Jonsson G; Sachs C
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):287-96. PubMed ID: 4144667
    [No Abstract]   [Full Text] [Related]  

  • 12. Neurochemical properties of adrenergic nerves regenerated after 6-hydroxydopamine.
    Jonsson G; Sachs C
    J Neurochem; 1972 Nov; 19(11):2577-85. PubMed ID: 5086245
    [No Abstract]   [Full Text] [Related]  

  • 13. 6-Aminodopamine-induced degeneration of catecholamine neurons.
    Jonsson G; Sachs C
    J Neurochem; 1973 Jul; 21(1):117-24. PubMed ID: 4720890
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of intraventricular injection of 6-hydroxydopamine in the developing kitten. II. On the central monoaminergic innervation.
    Bourgoin S; Adrien J; Laguzzi RF; Dolphin A; Bockaert J; Hery F; Hamon M
    Brain Res; 1979 Jan; 160(3):461-78. PubMed ID: 421125
    [No Abstract]   [Full Text] [Related]  

  • 15. Specific lysis by 6-hydroxydopamine of catecholaminergic synaptosomes prepared from rat cerebrum.
    Suzuki T; Okumura-Noji K; Tanaka R
    Brain Res; 1984 Nov; 321(2):374-6. PubMed ID: 6437604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of ( 3 H)noradrenaline and ( 3 H)dopamine from field stimulated cerebral cortex slices. Effect of tyrosine hydroxylase and dopamine- -hydroxylase inhibition.
    Farnebo LO; Hamberger B; Jonsson G
    J Neurochem; 1971 Dec; 18(12):2491-500. PubMed ID: 4400156
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of 6-hydroxydopamine on daily variations of 5-HT synthesis in the hypothalamus of the rat.
    Héry F; Rouer E; Clowinski J
    Brain Res; 1973 Aug; 58(1):135-46. PubMed ID: 4731196
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of 6-hydroxydopamine on the development of the beta adrenergic receptor/adenylate cyclase system in rat cerebral cortex.
    Harden TK; Wolfe BB; Sporn JR; Poulos BK; Molinoff PB
    J Pharmacol Exp Ther; 1977 Oct; 203(1):132-43. PubMed ID: 198523
    [No Abstract]   [Full Text] [Related]  

  • 19. Responses of sympathetic chain-ganglia isolated in organo-typic culture to agents affecting adrenergic neurons: fluorescence histochemistry.
    Benitez HH; Murray MR; Côté LJ
    Exp Neurol; 1973 Jun; 39(3):424-8. PubMed ID: 4145891
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of 6-hydroxydopamine lesions of the medial prefrontal cortex on neurotransmitter systems in subcortical sites in the rat.
    Pycock CJ; Carter CJ; Kerwin RW
    J Neurochem; 1980 Jan; 34(1):91-9. PubMed ID: 6161214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.